Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-06

Clinical Trial Update: Inactivated Poliovirus Vaccine (IPV) With or Without E.Coli Double Mutant Heat-Labile Toxin (dmLT) Challenge Study in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating inactivated poliovirus vaccine (IPV) with or without dmLT challenge in healthy adults; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Inactivated Poliovirus Vaccine (IPV) (Inactivated Poliovirus Vaccine)

Snippet

Sponsor: PATH | Conditions: Polio | Phase 1 | Status: COMPLETED | Results posted: 2022-09-06